Work

A Randomized, Open-Label, Phase II Study of Afatinib Versus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)32015-9

Authors: T.Y. Seiwert, J. Fayette, D. Cupissol, J.M. DelCampo, P.M. Clement, J.M. Tourani, M. Degardin, A.S. Blackman, J. Cong, F. Solca, E. Ehrnrooth, E.E.W. Cohen

Institutions: University of Chicago Medical Center, Centre Léon Bérard, Vall d'Hebron Hospital Universitari, KU Leuven, Université de Poitiers, Centre Hospitalier Universitaire de Poitiers, Centre Oscar Lambret, Boehringer Ingelheim (United States), Boehringer Ingelheim (Austria), Boehringer Ingelheim (Denmark)

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3000458017

FWCI: 4.669

Cites:

Cited by: 17

Related to: 10